Schrodinger, Inc. SDGR shares soared 27.4% in the last trading session to close at $24.49. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 12.4% loss over the past four weeks.

Schrodinger scored a strong price increase on investors’ optimism driven by the company’s announced that it has reached a settlement in a legal dispute concerning its compensation practices over non-employee directors. Furthermore, it is set to present new preclinical data on SGR-3515, an investigational Wee1/Myt1 inhibitor, and SGR-4174, a SOS1 inhibitor, at the American Association for Cancer Research (AACR) Annual Meeting 2025, taking place between April 25 - 30, 2025 in Chicago, IL. 

This company is expected to post quarterly loss of $0.71 per share in its upcoming report, which represents a year-over-year change of +6.6%. Revenues are expected to be $55.76 million, up 52.3% from the year-ago quarter.

While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For Schrodinger, the consensus EPS estimate for the quarter has been revised 2.8% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on SDGR going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Schrodinger is part of the Zacks Medical Info Systems industry. TruBridge TBRG, another stock in the same industry, closed the last trading session 0.7% lower at $24.38. TBRG has returned -10.5% in the past month.

For TruBridge , the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.37. This represents a change of +94.7% from what the company reported a year ago. TruBridge currently has a Zacks Rank of #3 (Hold).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Schrodinger, Inc. (SDGR) : Free Stock Analysis Report

TruBridge, Inc. (TBRG) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research